Vaccsys raises $9 million for vaccine research

June 20, 2008 | Eric Eldon
View Comments

Vaccsys, a company that does vaccine research, has raised $9 million of a planned $18 million round from Alta Partners, Versant Venture Capital and The Column Group.

Vaccsys’s web site is here, although it’s still under construction.

Update: As part of the new funding, Vaccsys is relaunching under a new name, Immune Design, according to VentureWire.

Next Story:
Previous Story:

Print
Email
Twitter
Facebook
Google Buzz
LinkedIn
Digg
StumbleUpon
Reddit
Delicious
Google
More...
Photo of Eric Eldon

About the Author,

Eric wrote about digital media for VentureBeat until August 2009. To reach VentureBeat's current writers, email tips@venturebeat.com.

blog comments powered by Disqus